White Diamond Research
Contributor since: 2016
Company: White diamond research
ZK International Is Building The Robinhood Of Crypto And CFD Trading
GreenPower Motor Had A 48% Revenue Decline In 2020 And Recent Events Suggest Revenues Won't Improve In 2021
Blue Bird Is An Undervalued Electric Vehicle Manufacturer Going Back To School With $100 Billion Of Federal Contracts In Its Grasp
At 25% Of Merged Company Value, Torchlight Looks To Be Worth Only $0.35/share
ZK International's DeFi Platform, Crypto ETF, And Upcoming Crypto Coin Could Hit The Jackpot
CleanSpark Is A Failed Business Roll-Up In A Vicious Court Battle With Its Largest Shareholder - $3 Price Target
Wrap Technologies: Disastrous LAPD BolaWrap Pilot Program Results, No Evidence These Have Been Communicated To Investors
After Researching Atomera, We Don't Believe Its Technology Works - $3 Price Target
MicroVision Has Risen Over 1000% On Delusional Retail Investor Dreams - $0.15 Price Target
Wrap Technologies Batman Device Is Mostly Impractical In The Real World - $3 Price Target
For Riot Blockchain To Just Break-Even, Bitcoin's Price Would Have To Average $19,000
Sell Canaan: Bitcoin Mining Is An Unprofitable Business That Just Got Worse
Why BioSig's Coronavirus Drug Likely Won't Work
There Doesn't Appear To Be Any Real Interest In Co-Diagnostics' Coronavirus Test - We Reiterate Our $1 Price Target
Evidence Suggests Dyadic's C1 Expression Platform Is Useless - $2 One-Year Price Target
Co-Diagnostics Coronavirus Test Is Likely Ineffective - $1 Price Target
Nymox Pharmaceuticals Has A Long History Of Broken Promises And Baffling Delays That Will Likely Continue
NanoViricides Will Return To $3-$5 As Soon As The Coronavirus Newsflow Fades
Alphatec Holdings' Products Lack Innovation And Losses Are Growing (Target Of $3, 50% Downside)
Accelerate Diagnostics Will Implode To Single Digits In The Near Term
Helius Medical's New Report Provides More Evidence That Its Device Is Ineffective
The Meet Group: Fade This Rally As Video Streaming Hype Is Likely To Fail - 50%+ Downside
The Enochian Biosciences Story Has Just Gotten Even More Bizarre
Enochian Biosciences Is A House Of Cards - The Pipeline Is Entirely Pre-Clinical And Management Has A Questionable History
United Health Products' Press Releases Cannot Be Taken At Face Value
Resonant Is A Good Short As Its XBAR Resonator Is Years Away From Commercialization
Accelerate Diagnostics Is About To Accelerate To The Downside - $6 Price Target
United Health Products Has An Absurd Valuation With Only A Me-Too Gauze Product From China
Evidence Suggests TransEnterix' Asset Sale Will Fall Through, Which Could Cause A Quick 50%+ Drop
Discovery Gold Corp. Is A $150M+ Empty Shell, False Company Statements - 98% Downside
Synthesis Energy Systems Is Essentially An Empty Shell With Debt - $1 Price Target
Last Quarter's Results Proves That TransEnterix' Surgical Robot Is A Total Failure